Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹1,322 Cr
Revenue (TTM)
₹211 Cr
Net Profit (TTM)
₹49 Cr
ROE
14.3 %
ROCE
18.7 %
P/E Ratio
26.8
P/B Ratio
3.6
Industry P/E
27.87
EV/EBITDA
18.2
Div. Yield
0.5 %
Debt to Equity
0.1
Book Value
₹1177
EPS
₹160.2
Face value
10
Shares outstanding
3,082,114
CFO
₹286.61 Cr
EBITDA
₹403.04 Cr
Net Profit
₹314.96 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Paushak
| -13.5 | -10.9 | 6.7 | -27.3 | -21.8 | 15.5 | 21.7 |
|
BSE Commodities
| 5.1 | -1.4 | 6.1 | -1.4 | 18.4 | 25.9 | -- |
|
BSE Small Cap
| -4.9 | 2.1 | 15.7 | 0.8 | 29.2 | 33.9 | 16.9 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Paushak
| -18.4 | -25.7 | -20.2 | 168.1 | 52.0 | 0.4 | 95.4 |
|
BSE Small Cap
| 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 | -23.4 |
|
BSE Commodities
| 8.1 | 17.5 | 1.2 | 61.5 | 26.1 | -4.6 | -19.2 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Paushak
|
4,287.8 | 1,321.6 | 210.9 | 49.4 | 21.2 | 10.9 | 26.8 | 3.6 |
| 73.3 | 2,161.7 | 2,000.3 | 30.3 | 4.7 | 2.9 | 71.4 | 2.1 | |
| 264.1 | 3,016.2 | 533.3 | 109.2 | 22.1 | 15.2 | 27.9 | 4.1 | |
| 4,483.4 | 2,875.0 | 550.8 | 78.9 | 15.9 | 24.4 | 36.5 | 7.9 | |
| 89.1 | 4,040.4 | 1,133.7 | 157.2 | 14.6 | 17.4 | 25.7 | 4.3 | |
| 1,815.0 | 5,610.7 | 9,039.0 | 184.5 | 4.4 | 10.5 | 24.3 | 2.5 | |
| 508.7 | 3,145.2 | 1,358.2 | 86.5 | 11.2 | 24.2 | 36.3 | 8.2 | |
| 355.8 | 3,117.8 | 1,059.2 | 57.5 | 10.5 | 14.8 | 54.2 | 7.7 | |
| 1,581.3 | 4,173.1 | 777.6 | 34.7 | 14.0 | 5.6 | 119.8 | 5.3 | |
| 292.5 | 2,999.5 | 2,049.5 | -46.1 | -0.6 | -3.9 | -- | 2.6 |
Paushak Limited develops, manufactures, and sells phosgene based specialty chemicals and intermediates in India and internationally. Its products include isocyanates, chloroformates, carbonates/carbamates, carbamoyl chlorides, and others. The company... primarily serves pharma, agro, and specialty chemical companies. Paushak Limited was incorporated in 1972 and is based in Vadodara, India. Read more
Incorporated
1972
Chairman
Chirayu Amin
Managing Director
--
Group
Alembic
Headquarters
Vadodara, Gujarat
Website
Looking for more details about Paushak Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Paushak Ltd stood at ₹ 572 Cr as on 31-Mar-25
The share price of Paushak Ltd is ₹4,287.80 (BSE) as of 19-Jun-2025 IST. Paushak Ltd has given a return of -21.83% in the last 3 years.
Paushak Ltd has a market capitalisation of ₹ 1,322 Cr as on 19-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Paushak Ltd is 3.64 times as on 19-Jun-2025, a 1% discount to its peers’ median range of 3.68 times.
The P/E ratio of Paushak Ltd is 26.76 times as on 19-Jun-2025, a 4% discount to its peers’ median range of 27.87 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Paushak Ltd and enter the required number of quantities and click on buy to purchase the shares of Paushak Ltd.
Paushak Limited develops, manufactures, and sells phosgene based specialty chemicals and intermediates in India and internationally. Its products include isocyanates, chloroformates, carbonates/carbamates, carbamoyl chlorides, and others. The company primarily serves pharma, agro, and specialty chemical companies. Paushak Limited was incorporated in 1972 and is based in Vadodara, India.
The prominent promoters of Paushak Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
Nirayu Limited |
41.15%
|
|
Alembic Limited |
19.07%
|
|
Chirayu Ramanbhai Amin |
2.91%
|
|
Malika Chirayu Amin |
1.22%
|
The chairman of the company is Chirayu Amin, and the managing director is .
There is no promoter pledging in Paushak Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
5,856
|
|
|
4,382
|
|
|
3,810
|
|
|
3,054
|
|
|
3,032
|
|
|
3,023
|
|
|
2,990
|
|
|
2,839
|
|
|
2,367
|
| Paushak Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
10.94
|
|
Operating margin(%)
|
21.18
|
|
Net Margin(%)
|
21.92
|
|
Dividend yield(%)
|
0.47
|
Yes, TTM profit after tax of Paushak Ltd was ₹49 Cr.
₹-54.70
(
